ArriVent BioPharma, Inc. Common Stock (AVBP) ownership: Top institutional holder: SUVRETTA CAPITAL MANAGEMENT, LLC ($101.53M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4401083.00 | $101.53M | 2026-03-31 |
| INFINITUM ASSET MANAGEMENT, LLC | 4148923.00 | $95.72M | 2026-03-31 |
| HHLR ADVISORS, LTD. | 3929117.00 | $90.64M | 2026-03-31 |
| ORBIMED ADVISORS LLC | 3027328.00 | $69.84M | 2026-03-31 |
| FMR LLC | 3016132.00 | $69.58M | 2026-03-31 |
| BlackRock, Inc. | 2530301.00 | $58.37M | 2026-03-31 |
| Octagon Capital Advisors LP | 1971054.00 | $45.47M | 2026-03-31 |
| NOVO HOLDINGS A/S | 1942142.00 | $44.81M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-02-02 | |
| Sell | null | 2026-02-02 | |
| Sell | null | 2026-02-02 | |
| Sell | null | 2026-02-02 | |
| Sell | null | 2026-02-02 | |
| Sell | null | 2026-02-02 | |
| Sell | null | 2026-02-02 | |
| Sell | null | 2026-02-02 |
Back to AVBP overview · AVBP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.